Agilon Health, Inc.
AGL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,435 | $1,395 | $1,533 | $1,522 |
| % Growth | 2.9% | -9% | 0.7% | – |
| Cost of Goods Sold | $1,510 | $1,447 | $1,482 | $1,561 |
| Gross Profit | -$75 | -$52 | $51 | -$38 |
| % Margin | -5.2% | -3.8% | 3.3% | -2.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $56 | $66 | $60 |
| SG&A Expenses | $52 | $56 | $66 | $60 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $7 | $7 | $10 |
| Operating Expenses | $52 | $64 | $73 | $70 |
| Operating Income | -$127 | -$116 | -$22 | -$108 |
| % Margin | -8.9% | -8.3% | -1.4% | -7.1% |
| Other Income/Exp. Net | $17 | $12 | $20 | $3 |
| Pre-Tax Income | -$111 | -$104 | -$2 | -$105 |
| Tax Expense | -$0 | $0 | $0 | $2 |
| Net Income | -$110 | -$104 | $12 | -$106 |
| % Margin | -7.7% | -7.5% | 0.8% | -6.9% |
| EPS | -0.266 | -0.25 | 0.03 | -0.26 |
| % Growth | -6.4% | -933.3% | 111.5% | – |
| EPS Diluted | -0.266 | -0.25 | 0.03 | -0.26 |
| Weighted Avg Shares Out | 414 | 414 | 413 | 412 |
| Weighted Avg Shares Out Dil | 414 | 414 | 413 | 412 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $7 | $7 | $7 | $6 |
| EBITDA | -$101 | -$95 | $7 | -$97 |
| % Margin | -7.1% | -6.8% | 0.4% | -6.3% |